Nonvitamin K Antagonist Oral Anticoagulants Reduced the Risk of Liver Injury in Atrial Fibrillation Patients

Am J Gastroenterol. 2021 May 1;116(5):1090. doi: 10.14309/ajg.0000000000000930.

Authors

Rongqiang Liu¹, Linsen Ye², Yi Shao³

Affiliations

¹ The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
² The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
³ The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

PMID: 33177348
DOI: 10.14309/ajg.0000000000000930

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants / adverse effects
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / epidemiology
Cohort Studies
Humans
Liver
Stroke* / epidemiology
Stroke* / etiology
Stroke* / prevention & control
Warfarin / adverse effects

Substances

Anticoagulants
Warfarin